Management of Oligometastatic Esophageal Adenocarcinoma
Case 1: Distal Esophageal Adenocarcinoma With Liver Metastases After Neoadjuvant Therapy
Patient Profile & Clinical Presentation
-
Patient: 59-year-old male in excellent condition
-
Clinical Presentation: Epigastric pain and weight loss for 2 months.
Initial Diagnostic Workup
-
Gastroscopy (April 2020): Lesion at the distal part of the esophagus (35-40 cm from dental arches), developed on Barrett esophagus.
-
Biopsy: Adenocarcinoma, HER-2 negative.
-
Staging: Thoraco-abdominal PET Scan and echo-endoscopy showed no metastatic disease.
Neoadjuvant Treatment
-
Regimen: CROSS protocol.
-
Period: May – June 2020.
Restaging
-
New staging with PET-Scan and Liver MRI revealed two liver metastases.
Case 2: Distal Esophageal Adenocarcinoma With Multiple Liver Metastases and Response to Systemic Chemotherapy
Patient Profile & Clinical Presentation
-
Patient: 58-year-old male
-
Medical History: Tobacco use, chronic obstructive pulmonary disease and sleep apnea.
-
Clinical Presentation: Dysphagia and hematemesis.
Initial Diagnostic Workup
-
Gastroscopy (April 2021): Lesion at the distal part of the esophagus (38-42 cm from dental arches).
-
Echo-endoscopy Staging: uT3 N2.
-
Biopsy: Adenocarcinoma, HER-2 negative.
-
Staging: Thoraco-abdominal PET Scan showed 4 liver metastases.
Systemic Treatment
-
Regimen: FLOT protocol.
-
Period: May – June 2021.
Restaging
-
New staging with PET-Scan and Liver MRI showed regression of liver metastases.
Discussion
Management of oligo metastases.
Panel for Discussion
Local Panel (Geneva): Stefan Mönig | Minoa Jung | Olivier Huber
International Multi-disciplinary Panel: T. Goëtze, Surgical Oncology (Frankfurt, Germany) | T. Schmidt, Surgical Oncology (Köln, Germany) | T.E. Kroese, Surgery (Utrecht, Netherland) | R. Langer, Pathology (Linz, Austria) | J. Wendelmayer, Surgery (Verona, Italy) | S. Schoppmann, Surgery (Vienna, Austria)
